Sun Pharmaceutical Industries Share Price Today - Live Blog for April 29, 2025

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.15%, with its current market value per share resting at ₹1,805.15. This development highlights the stock's appeal to investors.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.30%, with the current market value at ₹1,805.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd observed a -0.27% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,809.15. The stock has a PE ratio of 37.5000, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.25% drop, and it's now trading at ₹1,814.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.06% in its share price, and it currently trades at ₹1,818.50 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd witnessed a -0.08% drop in its share price and is currently trading at ₹1,820.10. With the stock's PE at 37.5000 and the industry PE at 34.2365, investors are weighing their options.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.04%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,820.50, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.02% decline and is currently trading at ₹1,820.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.00%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,820.50, and market participants are assessing the implications. The stock has a PE ratio of 37.5000, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.04% in its share price, and it currently trades at ₹1,820.60 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.